Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Restructuring Costs: 2010-2011

Historic Restructuring Costs for Lexicon Pharmaceuticals (LXRX) over the last 2 years, with Dec 2011 value amounting to $6.8 million.

  • Lexicon Pharmaceuticals' Restructuring Costs rose 0.19% to $1.6 million in Q4 2011 from the same period last year, while for Dec 2011 it was $6.8 million, marking a year-over-year change of. This contributed to the annual value of $6.8 million for FY2011, which is 149.67% up from last year.
  • As of FY2011, Lexicon Pharmaceuticals' Restructuring Costs stood at $6.8 million, which was up 149.67% from $2.7 million recorded in FY2010.
  • Lexicon Pharmaceuticals' Restructuring Costs' 5-year high stood at $6.8 million during FY2011, with a 5-year trough of $2.7 million in FY2010.
  • Moreover, its 2-year median value for Restructuring Costs was $4.7 million (2010), whereas its average is $4.7 million.
  • Data for Lexicon Pharmaceuticals' Restructuring Costs shows a peak YoY spiked of 149.67% (in 2011) over the last 5 years.
  • Yearly analysis of 2 years shows Lexicon Pharmaceuticals' Restructuring Costs stood at $2.7 million in 2010, then spiked by 149.67% to $6.8 million in 2011.